{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:45:07Z","timestamp":1788389107203,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the project of Administration of Traditional Chinese Medicine of Zhejiang province","award":["2021ZB019"],"award-info":[{"award-number":["2021ZB019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04417-9","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:09:54Z","timestamp":1759230594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Autoimmune nodopathy with anti-NF186 antibodies following SARS-CoV-2 infection: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Junmei","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"12","key":"4417_CR1","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1007\/s00415-020-10041-z","volume":"267","author":"E Delmont","year":"2020","unstructured":"Delmont E, Brodovitch A, Kouton L, Allou T, Beltran S, Brisset M, et al. Antibodies against the node of ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera. J Neurol. 2020;267(12):3664\u201372.","journal-title":"J Neurol"},{"issue":"9","key":"4417_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","volume":"13","author":"L Querol","year":"2017","unstructured":"Querol L, Devaux J, Rojas-Garcia R, Illa I. Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications. Nat Rev Neurol. 2017;13(9):533\u201347.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"4417_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/jns.12455","volume":"26","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, et al. European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision. J Peripher Nerv Syst. 2021;26(3):242\u201368.","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"4417_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-018-0027-2","volume":"4","author":"BC Kieseier","year":"2018","unstructured":"Kieseier BC, Mathey EK, Sommer C, Hartung HP. Immune-mediated neuropathies. Nat Rev Dis Primers. 2018;4(1):31.","journal-title":"Nat Rev Dis Primers"},{"issue":"Pt 6","key":"4417_CR5","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/brain\/aww062","volume":"139","author":"C Manso","year":"2016","unstructured":"Manso C, Querol L, Mekaouche M, Illa I, Devaux JJ. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects. Brain. 2016;139(Pt 6):1700\u201312.","journal-title":"Brain"},{"issue":"10","key":"4417_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","volume":"82","author":"L Querol","year":"2014","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R, Diaz-Manera J, Pardo J, Ortega-Moreno A, et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 2014;82(10):879\u201386.","journal-title":"Neurology"},{"issue":"6","key":"4417_CR7","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12026-023-09406-z","volume":"71","author":"F Ginanneschi","year":"2023","unstructured":"Ginanneschi F, Vinciguerra C, Volpi N, Piscosquito G, Barone P, Rossi A. Chronic inflammatory demyelinating polyneuropathy after SARS-CoV2 vaccination: update of the literature and patient characterization. Immunol Res. 2023;71(6):833\u20138.","journal-title":"Immunol Res"},{"issue":"4","key":"4417_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00415-020-10124-x","volume":"268","author":"S Abu-Rumeileh","year":"2021","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268(4):1133\u201370.","journal-title":"J Neurol"},{"key":"4417_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-245816","author":"V Suri","year":"2021","unstructured":"Suri V, Pandey S, Singh J, Jena A. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination. BMJ Case Rep. 2021. https:\/\/doi.org\/10.1136\/bcr-2021-245816.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"4417_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/brain\/awaa433","volume":"144","author":"S Keddie","year":"2021","unstructured":"Keddie S, Pakpoor J, Mousele C, Pipis M, Machado PM, Foster M, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome. Brain. 2021;144(2):682\u201393.","journal-title":"Brain"},{"issue":"23","key":"4417_CR11","doi-asserted-by":"publisher","first-page":"e2386","DOI":"10.1212\/WNL.0000000000207282","volume":"100","author":"H Al-Hakem","year":"2023","unstructured":"Al-Hakem H, Doets AY, Stino AM, Zivkovic SA, Andersen H, Willison HJ, et al. CSF findings in relation to clinical characteristics, subtype, and disease course in patients with Guillain-Barr\u00e9 syndrome. Neurology. 2023;100(23):e2386\u201397.","journal-title":"Neurology"},{"issue":"Pt 1","key":"4417_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014;137(Pt 1):33\u201343.","journal-title":"Brain"},{"issue":"Pt 10","key":"4417_CR13","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1093\/brain\/aww189","volume":"139","author":"K Doppler","year":"2016","unstructured":"Doppler K, Appeltshauser L, Villmann C, Martin C, Peles E, Kr\u00e4mer HH, et al. Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy. Brain. 2016;139(Pt 10):2617\u201330.","journal-title":"Brain"},{"issue":"23","key":"4417_CR14","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","volume":"79","author":"JK Ng","year":"2012","unstructured":"Ng JK, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T, et al. Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology. 2012;79(23):2241\u20138.","journal-title":"Neurology"},{"issue":"6","key":"4417_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","volume":"88","author":"H Koike","year":"2017","unstructured":"Koike H, Kadoya M, Kaida KI, Ikeda S, Kawagashira Y, Iijima M, et al. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies. J Neurol Neurosurg Psychiatry. 2017;88(6):465\u201373.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4417_CR16","doi-asserted-by":"publisher","first-page":"838222","DOI":"10.3389\/fneur.2022.838222","volume":"13","author":"S Wen","year":"2022","unstructured":"Wen S, Huang K, Zhu H, Li P, Zhou L, Feng L. Case report: anti-NF186\u2009+\u2009CIDP after receiving the inactivated vaccine for coronavirus disease (COVID-19). Front Neurol. 2022;13:838222.","journal-title":"Front Neurol"},{"issue":"5","key":"4417_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","volume":"25","author":"G Lucchese","year":"2020","unstructured":"Lucchese G, Fl\u00f6el A. SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones. 2020;25(5):731\u20135.","journal-title":"Cell Stress Chaperones"},{"key":"4417_CR18","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000639","author":"A Cortese","year":"2020","unstructured":"Cortese A, Lombardi R, Briani C, Callegari I, Benedetti L, Manganelli F, et al. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype. Neurol Neuroimmunol Neuroinflamm. 2020. https:\/\/doi.org\/10.1212\/NXI.0000000000000639.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"4417_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/jnnp-2019-320314","volume":"90","author":"HC Lehmann","year":"2019","unstructured":"Lehmann HC, Burke D, Kuwabara S. Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2019;90(9):981\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04417-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04417-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04417-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:09:55Z","timestamp":1759230595000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04417-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4417"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04417-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was approved by the Ethics Committee of Zhejiang Provincial People\u2019s Hospital [approval number: People\u2019s Hospital Ethics Review 2024 Miscellaneous No. (089)]. Written informed consent was obtained from the patient for participation in this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}